Study Stopped
Grant concluded.
Evaluation of Dexterous Terminal Device
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
Liberating Technologies, Inc. (LTI) has developed Pointdexter, a dexterous prosthetic fingertip that is integrated into a commercial prosthetic hand and allows for an additional fine grasp. The Pointdexter device interfaces with upper limb prostheses by swapping the usual prosthetic pointer finger with the Pointdexter device. The dexterous prosthetic fingertip utilizes the same control strategy used to operate the prosthetic hand. This solution aims to combine the advantages of the common terminal devices into one product by combining the practicality and dexterity of a split-hook or gripper with the aesthetics of multi-articulating hands.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Dec 2022
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 22, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 20, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 20, 2023
CompletedFirst Submitted
Initial submission to the registry
April 21, 2023
CompletedFirst Posted
Study publicly available on registry
May 3, 2023
CompletedNovember 25, 2024
November 1, 2024
4 months
April 21, 2023
November 21, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Jebsen-Taylor Small Common Objects Functional Test
During the in-lab portion of the study, subjects will be asked to complete the 'small common objects' subtask of the Jebsen-Taylor Hand Function Test, which assesses a broad range of unimanual hand functions required for ADLs. The primary quantitative measure of the Jebsen-Taylor task will be completion time of each subtask. This test will be used to evaluate the feasibility of the device design as compared with the unmodified prosthetic hand.
4 hours
Secondary Outcomes (1)
User Feedback
4 hours
Study Arms (2)
Pointdexter
EXPERIMENTALThe investigational device being tested is Pointdexter, a novel prosthetic finger with a built-in split gripper. The device is an index finger which can drop in place of existing fingers on a prosthetic hand. The investigational device is controlled with the same signals used to control the hand. Participants will use a commercially available prosthetic hand compatible with the Pointdexter device for this study.
Comparator
ACTIVE COMPARATORThe comparator device is the same commercially available hand that is being used for the Pointdexter arm, except that it will be unmodified (i.e., it will have its usual index finger attached instead of the Pointdexter finger).
Interventions
Commercially available prosthetic hand modified with the investigational Pointdexter finger in place of the usual index finger.
Eligibility Criteria
You may qualify if:
- Have an upper limb absence
- Uses myoelectric control for their prosthesis
- If they have a major upper limb absence, must use a quick-disconnect wrist
- If able-bodied, must be willing to use an upper-limb prosthesis bypass for testing
- Willing and able to complete activities outlined in the study and provide requested feedback.
- Adults must be able to provide their own consent.
You may not qualify if:
- The risks to pregnant people and fetuses are unknown and therefore those who are pregnant should not participate in the study and will be screened by self-disclosure.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Links
MeSH Terms
Conditions
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 21, 2023
First Posted
May 3, 2023
Study Start
December 22, 2022
Primary Completion
April 20, 2023
Study Completion
April 20, 2023
Last Updated
November 25, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share
Study withdrawn - no participants recruited and no data collected.